Thursday, April, 18, 2019 08:43:21

Category: Pharmaceuticals

Dermira to launch new campaign called ‘Life Unfolds’ featuring QBREXZA

The latest multi-channel consumer campaign is likely to feature several QBREXZA patients Dermira Inc., a US-based biopharmaceutical company, is currently in the news for introducing a brand-new direct-to-consumer campaign known as ‘Life Unfolds’, which has been strategized to spread awareness of QBREXZA™ treatment. As per …

Zulresso wins FDA approval as the first post-partum depression drug

Zulresso will be provided through a restricted program in which a healthcare expert administers the drug in an authorized health facility Reports confirm that the U.S. Food and Drug Administration has recently approved Zulresso injection for the treatment of Post-Partum depression (PPD) in adult women. …

Sun Pharma’s SPARC inks a research collaboration deal with HitGen

The research collaboration pact is aimed at identifying unique small molecule leads for targets of interest HitGen would apply its high-grade technology platform to find unique leads for SPARC Sun Pharma Advanced Research Company (SPARC), the research arm of India-based multinational drug manufacturer Sun Pharmaceutical …

GeoVax, Leidos to develop malaria vaccines under extended partnership

As a part of an expanded collaboration, GeoVax Labs Inc., an American biotechnology company and Leidos Inc., a scientific research company, have reportedly announced the development of malaria vaccine candidates. The USAID (United States Agency for International Development) MVDP (Malaria Vaccine Development Program) is reported …

U.S. FDA grants Fast Track designation for Iovance’s LN-145 therapy

With the Fast Track designation, Iovance is likely to increase the frequency of its communication with the U.S. FDA. Reputed biotechnology company Iovance Biotherapeutics, Inc., has reportedly been granted the Fast Track designation for its adoptive cell therapy LN-145, developed using its proprietary TIL manufacturing …